title: A cost density analysis of benign prostatic hyperplasia.
abstract: We assessed the frequency and cost of care for benign prostatic hyperplasia (BPH) among approximately 165,000 subscribers to Fallon Community Health Plan (FCHP), a group model health maintenance organization located in central Massachusetts. We computed rates of episodes of medical services for BPH using automated utilization files, and we estimated costs using Medicare reimbursement schedules and medication average wholesale prices. We identified 3919 men who visited a physician for BPH from January 1, 1991, until December 31, 1994, during which time they contributed 8336 person-years to the analysis. This population comprises approximately 12% of men at least 40 years old at FCHP. From 1991 to 1994, 696 (18%) men received terazosin, 219 (6%) men underwent a prostatectomy, and 41 (1%) men received finasteride. Men averaged 1.66 office visits per year to a physician for BPH. Most office visits (61%) were to a primary care physician, with 39% of the visits to a urologist. Among patients who received terazosin, the frequency of office visits increased slightly after receiving terazosin, from 2.14 to 2.62 visits per year. Among surgery patients, the frequency of visits declined after prostatectomy, from 6.31 visits per year to 1.67 visits. The individual annual cost rate for BPH care ranged from $25.00 to $25,352.00, with an average of $364.00 per person and a median cost of $126.00. The major components of the overall costs were hospital admissions (35%), terazosin dispensings (29%), and physician office visits (19%), with outpatient hospital care and ambulatory procedures accounting for the remaining 17%. Among men receiving terazosin, the average cost was $1190.00 per person-year, and among patients undergoing prostatectomy, the cost was $2630.00 per person-year. The prostatectomy rate declined by nearly 80% during the study period, while the dispensing rate for terazosin doubled, resulting in an overall decline in the total cost of care for BPH from 1991 to 1994.
authors.affiliation: Epidemiology Resources Inc., Newton Lower Falls, Massachusetts, USA.
authors.forename: S F
authors.initials: SF
authors.lastname: Lanes
authors.forename: S
authors.initials: S
authors.lastname: Sulsky
authors.forename: A M
authors.initials: AM
authors.lastname: Walker
authors.forename: J
authors.initials: J
authors.lastname: Isen
authors.forename: C E
authors.initials: CE
authors.lastname: Grier
authors.forename: B E
authors.initials: BE
authors.lastname: Lewis
authors.forename: N A
authors.initials: NA
authors.lastname: Dreyer
mesh_terms: D000328:Adult; D000368:Aged; D016527:Drug Costs; D017048:Health Care Costs; D017721:Hospital Costs; D006801:Humans; D015994:Incidence; D008297:Male; D008404:Massachusetts; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000191:economics*